glp-1 agonist moa Consensus Recommendations on RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force | Diabetes Therapy Graphical presentation of the mechanism

doi: 10.3389/fnins.2025.1671955 Received 24 July 2025 Revised 10 December 2025 Accepted 16 December 2025 Published 13 January 2026 Volume 19 - 2025 Edited by Fangchen Gong, Shanghai Jiao Tong University, China Reviewed by Al-Shaimaa Faissal Ahmed, Minia University, Egypt John Sieh Dumbuya, Affiliated Hospital of Guangdong Medical University, China Updates Copyright 2026 Li, Wang, Ma, Peng, Wang, Wang, Li and Wang

Chronic oral administration of high doses of levocarnitine in patients with severe renal impairment or end stage renal insufficiency (ESRD) and dialysis may induce an accumulation of the potentially toxic metabolites trimethylamine (TMA) etrimethylamine-N-oxide (TMAO), in how much these metabolites are normally excreted in the urine

GuptaNMiyauchiSMartindaleRGHerdmanAVPodolskyRMiyakeKet al

Cavinato, spsampsps K